EFG Hermes advises on $190m investment in Alameda Healthcare
EFG Hermes, an EFG Holding company and the leading investment bank in the Middle East and North Africa, announced it has acted as the Sole M&A Financial Advisor on a landmark $190m minority stake investment in Alameda Healthcare, one of Egypt's top private healthcare providers.
Read-
The investment was led by Development Partners International (DPI) in partnership with a consortium of institutional investors and development finance institutions. Following the transaction, Dr Fahad Khater, Chairman of Alameda, will remain the majority shareholder. The deal, primarily structured as a capital increase, is pending regulatory approvals and is expected to close in Q3 2025.
This marks the largest foreign direct investment in Egypt's healthcare sector to date, reinforcing investor confidence in Egypt's high-growth, resilient industries. The transaction will inject foreign currency into Egypt's banking system and support Alameda's expansion both locally and in the GCC markets.
Strategic expansion supported by capital injection
'This is a proud moment for EFG Hermes as we continue to deliver on our promise to guide clients through transformational transactions,' said Maged El Ayouti, Co-Head of Investment Banking at EFG Hermes.
'Securing a $190m investment for one of the region's fastest-growing healthcare platforms reflects our strong advisory capabilities and deep market expertise.'
Alameda, under Dr Khater's leadership, plans to use the proceeds to scale its hospital operations and increase clinical capacity. The funding will support expansion in Egypt, Saudi Arabia, the UAE, and other GCC countries, bolstering its position as a regional healthcare leader.
El Ayouti added that the firm's advisory role in this transaction is part of a broader track record of M&A excellence. Over the past 18 months, EFG Hermes has advised on M&A deals worth more than $2.5bn. Since the start of 2025, the investment bank has closed four M&A transactions, along with seven DCM and seven ECM deals across Egypt, the UAE, Saudi Arabia, and Oman.
The investment represents a key milestone in both Alameda's growth journey and EFG Hermes's continued dominance in regional capital markets.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
8 minutes ago
- Zawya
Cushman & Wakefield: China Leads REIT Market Expansion in Asia while India's REIT Market Demonstrates Robust Growth
HONG KONG SAR - Media OutReach Newswire – 17 July 2025 – China and India's Real Estate Investment Trust (REIT) markets showed robust growth in 2024 and are expected to continue to attract strong investor interest this year, according to Cushman & Wakefield's Asia REIT Market Insight 2024-2025. The annual report revealed that the Chinese mainland REIT (C-REIT) market achieved a remarkable 85% increase in market value at the end of 2024, surpassing Hong Kong and becoming one of the region's top three REIT markets. In the same period, India's REIT market demonstrated robust growth in the office sector, driven by strong leasing demand for institutional-grade office space. Meanwhile, mature markets such as Japan, Singapore and Hong Kong moved toward stabilization, underlining their long-term resilience. Catherine Chen, Director, Investor Client Intelligence & Insights, Asia Pacific at Cushman & Wakefield said, "The unprecedented growth in the C-REIT market highlights its role as a critical driver of regional expansion, while India's performance emphasizes the growing strength of the country's institutional-grade real estate. These markets continue to create new and exciting opportunities for investors targeting Asia." Cushman & Wakefield's data showed a total of 263 active REIT products in the Asia market as of December 31, 2024, with a combined market value of US$235.8 billion, reflecting a year-on-year decline of 6.5%. The contraction was primarily driven by declines in the U.S. dollar values of the Japan, Singapore and Hong Kong markets due to the widespread softening in REIT stock prices and unfavorable exchange rate movements. Amid these declines, the Chinese mainland REIT market emerged as a bright spot, posting an impressive 85% year-on-year rise in market value, attributable to new REIT product issuances and strong investor demand for infrastructure-backed assets. In the mature markets, Japanese REITs experienced significant gains in dividend yield, led by stock price moderation and asset performance improvements, particularly among hotel REITs, which benefited from inbound tourism. In Singapore, positive total returns were observed across multiple property types in 2024, including data centres at 9.7%, and healthcare at 6.9%. Elsewhere in Asia, Thailand demonstrated robust performance with a 41% increase in market value, marking it as the second-highest growth market in the region. The Philippines, Malaysia and India reported increases of 37%, 21% and 13% respectively, supported by their favorable economic fundamentals and attractive real estate sectors. Total Market Value of Active REITs on Major Asia Exchanges (December 2024) Market Number of REITs Market Value (USD billion) Market Share (%) Japan 57 90.8 38.5 Singapore 39 67.4 28.6 Chinese Mainland 58 21.4 9.1 Hong Kong, China 11 16.1 6.8 India 4 11.0 4.6 Thailand 38 8.3 3.5 Malaysia 18 7.7 3.2 The Philippines 8 5.8 2.5 South Korea 24 5.3 2.3 Taiwan, China 6 21.0 0.9 Total 263 235.8 100 Source: Bloomberg database, compiled by Cushman & Wakefield Valuation & Advisory Services Expansion of C-REIT market The year 2024 saw a breakthrough in C-REIT issuance with 29 new REIT products, including 19 real estate-backed REITs. This represented the highest annual issuance recorded to date. Among product categories, consumer infrastructure REITs led the issuance count with seven new listings, followed by industrial park REITs with six launches. Heading into 2025, the market has maintained its robust trajectory with six REITs launched in Q1, including five real estate-backed products. As of March 31, 2025, a total of 64 public infrastructure REITs were listed in the Chinese mainland, marking a significant period of growth in the market. Chris Yang, Senior Director, Head of REITs Practice Group, China, at Cushman & Wakefield said, "The C-REIT market has achieved a historic milestone in 2024, in both market value expansion and new product issuance. This surge reflects both greater investor confidence in infrastructure-backed REITs and the success of new issuances in retail and industrial REITs. Looking ahead, we anticipate further diversification and expansion as regulatory frameworks evolve to attract both domestic and international investors." Global capability centres drive leasing demand for India office REITs India's office asset REITs have attracted a considerable share of demand from global capability centres (GCCs), which is an important growth driver for India's office markets. At a Pan-India level, GCCs have accounted for 28%–29% of gross leasing volume on average over the last four quarters up to Q1 2025. In contrast, REIT landlords were able to achieve a much higher share, at 40%–60% of total leasing demand from GCC firms, rendering institutionally owned assets the preferred choice for many multinational occupiers. Somy Thomas, Executive Managing Director, Valuations and Co- Head, Capital Markets, India at Cushman & Wakefield commented, "India's REIT market continues to carve a strong trajectory, with exceptional growth seen across the office sector. Multinational companies, especially GCCs have driven record leasing activity, which now accounts for a significant share of the nation's Grade A office stock. There has also been a growing preference among occupiers for premium grade assets, thereby significantly benefiting REITs. All three office REITs in India achieved occupancy rates close to 90% at the end of Q1 2025." A fourth office REIT in India is expected to make its listing debut by the end of the calendar year 2025. With 48 million sq ft of Pan-India Grade A office space (37 million sq ft operational and 11 million sq ft under development), Knowledge Realty Trust, which is backed by Blackstone and Sattva Developers is expected to become one of the largest real estate investment trusts listed in India. Looking Ahead The Asia REIT market is poised for continued evolution as it navigates the dual forces of mature market stabilization and emerging market expansion. "We expect the mature markets of Japan, Singapore and Hong Kong to focus on enhancing operational efficiencies while grappling with the challenges posed by global monetary policy shifts. On the other hand, emerging markets, particularly the Chinese mainland, India and Thailand are expected to continue to grow, bolstered by strong economic fundamentals and supportive regulatory frameworks", noted Catherine Chen. Cushman & Wakefield's report also noted that data centre and hospitality REITs are expected to remain highly visible on investors' radar, driven by AI advancements and recovery in the tourism sector respectively. Additionally, M&A activity is likely to pick up as players seek scale and diversification to better weather market fluctuations. Please click here to download the report. Hashtag: #Cushman&Wakefield The issuer is solely responsible for the content of this announcement. Cushman & Wakefield Cushman & Wakefield (NYSE: CWK) is a leading global commercial real estate services firm for property owners and occupiers with approximately 52,000 employees in nearly 400 offices and 60 countries. In Greater China, a network of 23 offices serves local markets across the region. In 2024, the firm reported revenue of $9.4 billion across its core services of Valuation, Consulting, Project & Development Services, Capital Markets, Project & Occupier Services, Industrial & Logistics, Retail, and others. Built around the belief that Better never settles, the firm receives numerous industry and business accolades for its award-winning culture. For additional information, visit or follow us on LinkedIn ( Cushman & Wakefield
Tahawul Tech
38 minutes ago
- Tahawul Tech
Artificial Intelligence set to revolutionise healthcare's future, says Dr. Azad Moopen
Dubai — From an inundation in real-time data and its analysis, to a quantum leap in diagnosis and precision-guided solutions, Artificial Intelligence in health care is poised to be a complete game changer in the sector. The changes are there for everyone to see. In 2025 alone, global artificial intelligence (AI) in the healthcare market was valued at $39.25 billion, and it's expected to grow to $504.17 billion by 2032. That figure is more than a bullish forecast; it's a signpost pointing to the radical reimagining of healthcare as we know it. Across hospitals, clinics, and health tech labs from Abu Dhabi to Zimbabwe, AI is not just making inroads; it's redrawing the entire map of medicine. In the UAE, a nation committed to becoming a global leader in digital health, this revolution is being embraced with extraordinary speed. From robotic surgeries to AI-driven health records and predictive analytics, to the future of medicine, AI is here to stay. And it's making intelligent decisions that can make a difference between life and death. Especially around precision diagnosis. Reducing the margin of error A misdiagnosis can be fatal. Yet, diagnostic errors affect an estimated 12 million adults annually in the United States. That's where AI promises a quantum leap. Machine learning algorithms, fed on vast datasets of medical imaging, lab results, and patient histories, can detect abnormalities at a precision level humans simply cannot match. For example, Google Health's AI system has demonstrated greater accuracy than human radiologists in spotting breast cancer in mammograms. A landmark study published in Nature found that Google's deep learning AI reduced both false positives and false negatives compared to radiologists in both US and UK datasets. Meanwhile, DeepMind's AlphaFold, an AI system developed by the Google subsidiary, has cracked the protein folding problem, a breakthrough that could accelerate drug discovery and disease understanding exponentially. In the UAE, the Department of Health – Abu Dhabi (DoH) has launched Malaffi, the region's first Health Information Exchange, aiming to use AI to centralise and analyse patient data across providers. The ability to use this data to predict, rather than merely treat, illnesses could shift healthcare from a reactive to a preventive model. Diagnoses and resolution AI doesn't just diagnose; it also prescribes. Clinical decision support systems (CDSS) are now guiding doctors through labyrinths of data to arrive at the best course of treatment, not just generally, but for specific individuals. IBM Watson for Oncology, trained by oncologists at Memorial Sloan Kettering Cancer Center, has been assisting physicians globally by recommending personalised cancer treatments based on clinical evidence. 'In the UAE, AI is already augmenting healthcare through robot-assisted surgeries at hospitals like the Cleveland Clinic Abu Dhabi, Aster, Medcare, and Mediclinic. These systems offer precision, reducing recovery times and surgical risks.' Opening channels of accessibility to expertise But the real power lies in the democratisation of this expertise. Through cloud-based platforms and mobile apps, AI-driven diagnostics and treatment recommendations could soon be available even in remote regions of the world, addressing longstanding inequities in access to care. Imagine knowing you are likely to develop a certain disease, not from vague probabilities but with high certainty, years before any symptoms appear. That's not science fiction; that's predictive analytics – something AI can do with great precision. AI systems now analyse through reams of patient data, genomic information, and real-time wearable sensor data to identify at-risk individuals. For instance, Mount Sinai's AI research has produced significant advances, particularly in coronary artery disease prediction using electronic health records (EHRs) In the Gulf, where lifestyle-related diseases like Type 2 diabetes and cardiovascular issues are prevalent, such tools are not only welcome they are necessary. The Dubai Health Authority (DHA) is already piloting AI-based prediction models for chronic conditions, and wearable integration with digital health platforms is underway. The fusion of wearables with AI is particularly transformative. A UAE-based healthcare entity recently partnered with global tech players to pilot remote monitoring systems, allowing doctors to track patients' vitals in real time and intervene early turning reactive care into proactive protection. If the trends are any indication, the future hospital will not only treat patients better but run smarter. AI-powered logistics, staffing algorithms, and patient-flow management systems are already optimising operations, reducing wait times, and improving outcomes. In SEHA's flagship Sheikh Shakhbout Medical City, AI is being used to streamline triage and improve emergency room response times. Globally, institutions like Johns Hopkins Hospital in the U.S. are using predictive models to anticipate ICU demands, freeing up resources in advance and preventing crises. These smart hospitals are not just defined by flashy tech but by a philosophy: data-driven care that is seamless, efficient, and human-centric. Ethical Guardrails The AI-in-healthcare narrative isn't without its ethical dilemmas. Questions of data privacy, algorithmic bias, and accountability loom large. But that's where governance and regulation step in. In the UAE, the National Strategy for AI 2031 includes strong frameworks for ethical AI use, ensuring transparency, data protection, and oversight. Importantly, AI is not about replacing doctors but about enhancing their capacity. It frees clinicians from paperwork and routine diagnostics so they can focus on what machines can't replicate: compassion, creativity, and critical thinking. The question is not whether AI will change healthcare, but how boldly and responsibly we will embrace that change. This opinion piece is authored by Dr. Azad Moopen, Founder Chairman, Aster DM Healthcare.
The National
38 minutes ago
- The National
Samsung backs 'connected care' to mend broken health systems
Samsung Electronics is betting that digital and connected care will be able to mend broken healthcare systems as it seeks to expand its reach in a category beyond its core businesses. The South Korean company, in the lead-up to its Unpacked event last week, announced its acquisition of Xealth, a Seattle-based provider of digital health tools, for an undisclosed amount. The move, Samsung says, will help its connected care ambitions and help to bridge a 'holistic approach to preventive care to as many people as possible'. Scaling connected care is expected to be the next step in the future of health that would help fix broken healthcare systems, industry executives said at a forum on the sidelines of Unpacked. 'Health care is broken and part of the main reason it's broken is … [that] the incentives are misaligned. We know this from our everyday habits; if we are incentivising our kids to do the right things, they will do more of the right things,' Dr Rasu Shrestha, chief innovation and commercialisation officer of Charlotte-based health care provider Advocate Health, said at the forum. 'But if the incentives are misaligned, then the entire system starts to fall apart. So the opportunity here is … a connected ecosystem of devices and data really going after the dignity of those patients and consumers in a much more connected way.' Research suggests that while conservative care works, it is inconvenient, hard to access and expensive, said Jim Pursley, president of Hinge Health, a Chicago-based software developer. But technology can address this. 'The [good] thing with digital health in general is we've operated historically independent of institutional health care, independent of an advocate,' he said. Mr Pursley mentioned how tech has transformed the banking industry, with lenders able to provide on-demand services through devices, most notably through smartphone apps. 'The next decade of innovation is … to show that we can integrate with traditional in-person care to create a unified experience for patients, like banking,' he added. Global investments in the digital health sector hit more than $25 billion last year, a 5.5 per cent annual rise and reversing two consecutive years of a funding drop, according to data from Galen Growth, a Singapore-based industry tracker. Samsung is focusing on health and the division has been active in research and development, in addition to signing partnerships and acquisitions to expand its reach. It is linking up with start-ups to develop health services on its Galaxy smartphones and smartwatches. Samsung's AI push will help its strategy, and further expanding into health care will continue to remain a priority, said Dr Hon Pak, head of Samsung's digital health unit. 'I do feel that in 10 years, We're finally going to get to a point where health care is not about surviving – it's about thriving [using technology],' added Mr Pursley. 400 million Galaxy devices in 2025 Meanwhile, Samsung's plan to distribute 400 million Galaxy devices in 2025 is expected to be boosted by a push into ambient AI, a separate forum heard at Unpacked. That would double the current reach of Galaxy devices, TM Roh, head of Samsung's mobile division, said at the event. Ambient AI, which combines data analysis, machine learning, data analytics and natural language processing with humanlike behaviour, aims to provide personalised experiences. In health care, that can translate to improved patient care, operational efficiency and information extraction, according to the Morsani College of Medicine. 'Some see AI as the start of a 'post smartphone' era, but we see it differently: the smartphone is becoming even more central to an ambient AI experience,' said Jisun Park, a corporate executive vice president at Samsung. In addition, AI becoming more personalised needs a commitment to protect user information, and ambient AI's privacy, performance and personalisation 'go hand in hand, [as] they are not competing priorities, but co-equal standards', added Vinesh Sukumar, vice president of product management at US chipmaker Qualcomm Technology.
